The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medical Hyaluronic Acid Viscosupplementation Market Research Report 2025
Synopsis
Medical hyaluronic acid viscosupplementation is a medical procedure used to treat osteoarthritis, a degenerative joint disease that primarily affects the knees. It involves the injection of hyaluronic acid into the affected joint to provide temporary relief from pain and improve joint function. Hyaluronic acid is a natural component of synovial fluid, which lubricates and cushions the joints, and its viscosupplementation aims to supplement the diminished or degraded hyaluronic acid in osteoarthritic joints.
Global Medical Hyaluronic Acid Viscosupplementation market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Hyaluronic Acid Viscosupplementation market research.
Medical hyaluronic acid Viscosupplementation is a widely used non-surgical treatment for osteoarthritis, primarily affecting the knee joint. The procedure involves injecting hyaluronic acid directly into the affected joint to provide temporary pain relief, improve joint lubrication, and enhance mobility. The global market for medical hyaluronic acid viscosupplementation is driven by factors such as the growing aging population, increasing awareness about non-surgical treatment options for osteoarthritis, and advancements in medical technology. North America holds a significant share in the global medical hyaluronic acid viscosupplementation market, driven by a large aging population and a high prevalence of osteoarthritis. The region's well-established healthcare infrastructure and reimbursement policies also contribute to market growth. Europe is another prominent market for medical hyaluronic acid viscosupplementation, supported by a growing geriatric population and increasing awareness about non-surgical treatments for osteoarthritis. The Asia-Pacific region is witnessing rapid market growth due to the rising incidence of osteoarthritis, improving healthcare infrastructure, and increasing adoption of advanced medical technologies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Hyaluronic Acid Viscosupplementation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Anika Therapeutics
Genzyme (Sanofi)
Bioventus
Seikagaku Corporation
LG Chem
Zimmer Biomet
Swiss Biomed Orthopaedics
TRB Chemedica
KalVista Pharma
Macopharma
Segment by Type
Single Injections
Multiple Injections
Segment by Application
Knee Osteoarthritis
Hip Osteoarthritis
Ankle Osteoarthritis
Shoulder Osteoarthritis
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Hyaluronic Acid Viscosupplementation report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Medical hyaluronic acid viscosupplementation is a medical procedure used to treat osteoarthritis, a degenerative joint disease that primarily affects the knees. It involves the injection of hyaluronic acid into the affected joint to provide temporary relief from pain and improve joint function. Hyaluronic acid is a natural component of synovial fluid, which lubricates and cushions the joints, and its viscosupplementation aims to supplement the diminished or degraded hyaluronic acid in osteoarthritic joints.
Global Medical Hyaluronic Acid Viscosupplementation market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medical Hyaluronic Acid Viscosupplementation market research.
Medical hyaluronic acid Viscosupplementation is a widely used non-surgical treatment for osteoarthritis, primarily affecting the knee joint. The procedure involves injecting hyaluronic acid directly into the affected joint to provide temporary pain relief, improve joint lubrication, and enhance mobility. The global market for medical hyaluronic acid viscosupplementation is driven by factors such as the growing aging population, increasing awareness about non-surgical treatment options for osteoarthritis, and advancements in medical technology. North America holds a significant share in the global medical hyaluronic acid viscosupplementation market, driven by a large aging population and a high prevalence of osteoarthritis. The region's well-established healthcare infrastructure and reimbursement policies also contribute to market growth. Europe is another prominent market for medical hyaluronic acid viscosupplementation, supported by a growing geriatric population and increasing awareness about non-surgical treatments for osteoarthritis. The Asia-Pacific region is witnessing rapid market growth due to the rising incidence of osteoarthritis, improving healthcare infrastructure, and increasing adoption of advanced medical technologies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Medical Hyaluronic Acid Viscosupplementation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Anika Therapeutics
Genzyme (Sanofi)
Bioventus
Seikagaku Corporation
LG Chem
Zimmer Biomet
Swiss Biomed Orthopaedics
TRB Chemedica
KalVista Pharma
Macopharma
Segment by Type
Single Injections
Multiple Injections
Segment by Application
Knee Osteoarthritis
Hip Osteoarthritis
Ankle Osteoarthritis
Shoulder Osteoarthritis
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Medical Hyaluronic Acid Viscosupplementation report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Medical Hyaluronic Acid Viscosupplementation Market Overview
1.1 Product Overview and Scope of Medical Hyaluronic Acid Viscosupplementation
1.2 Medical Hyaluronic Acid Viscosupplementation Segment by Type
1.2.1 Global Medical Hyaluronic Acid Viscosupplementation Market Value Comparison by Type (2023-2029)
1.2.2 Single Injections
1.2.3 Multiple Injections
1.3 Medical Hyaluronic Acid Viscosupplementation Segment by Application
1.3.1 Global Medical Hyaluronic Acid Viscosupplementation Market Value by Application: (2023-2029)
1.3.2 Knee Osteoarthritis
1.3.3 Hip Osteoarthritis
1.3.4 Ankle Osteoarthritis
1.3.5 Shoulder Osteoarthritis
1.3.6 Others
1.4 Global Medical Hyaluronic Acid Viscosupplementation Market Size Estimates and Forecasts
1.4.1 Global Medical Hyaluronic Acid Viscosupplementation Revenue 2018-2029
1.4.2 Global Medical Hyaluronic Acid Viscosupplementation Sales 2018-2029
1.4.3 Global Medical Hyaluronic Acid Viscosupplementation Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Hyaluronic Acid Viscosupplementation Market Competition by Manufacturers
2.1 Global Medical Hyaluronic Acid Viscosupplementation Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Hyaluronic Acid Viscosupplementation Average Price by Manufacturers (2018-2023)
2.4 Global Medical Hyaluronic Acid Viscosupplementation Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Hyaluronic Acid Viscosupplementation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Hyaluronic Acid Viscosupplementation, Product Type & Application
2.7 Medical Hyaluronic Acid Viscosupplementation Market Competitive Situation and Trends
2.7.1 Medical Hyaluronic Acid Viscosupplementation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Hyaluronic Acid Viscosupplementation Players Market Share by Revenue
2.7.3 Global Medical Hyaluronic Acid Viscosupplementation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Hyaluronic Acid Viscosupplementation Retrospective Market Scenario by Region
3.1 Global Medical Hyaluronic Acid Viscosupplementation Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Hyaluronic Acid Viscosupplementation Global Medical Hyaluronic Acid Viscosupplementation Sales by Region: 2018-2029
3.2.1 Global Medical Hyaluronic Acid Viscosupplementation Sales by Region: 2018-2023
3.2.2 Global Medical Hyaluronic Acid Viscosupplementation Sales by Region: 2024-2029
3.3 Global Medical Hyaluronic Acid Viscosupplementation Global Medical Hyaluronic Acid Viscosupplementation Revenue by Region: 2018-2029
3.3.1 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Region: 2018-2023
3.3.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Region: 2024-2029
3.4 North America Medical Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.4.1 North America Medical Hyaluronic Acid Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Hyaluronic Acid Viscosupplementation Sales by Country (2018-2029)
3.4.3 North America Medical Hyaluronic Acid Viscosupplementation Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.5.1 Europe Medical Hyaluronic Acid Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Hyaluronic Acid Viscosupplementation Sales by Country (2018-2029)
3.5.3 Europe Medical Hyaluronic Acid Viscosupplementation Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Hyaluronic Acid Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Hyaluronic Acid Viscosupplementation Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Hyaluronic Acid Viscosupplementation Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.7.1 Latin America Medical Hyaluronic Acid Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Hyaluronic Acid Viscosupplementation Sales by Country (2018-2029)
3.7.3 Latin America Medical Hyaluronic Acid Viscosupplementation Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical Hyaluronic Acid Viscosupplementation Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Hyaluronic Acid Viscosupplementation Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Hyaluronic Acid Viscosupplementation Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Hyaluronic Acid Viscosupplementation Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Hyaluronic Acid Viscosupplementation Sales by Type (2018-2029)
4.1.1 Global Medical Hyaluronic Acid Viscosupplementation Sales by Type (2018-2023)
4.1.2 Global Medical Hyaluronic Acid Viscosupplementation Sales by Type (2024-2029)
4.1.3 Global Medical Hyaluronic Acid Viscosupplementation Sales Market Share by Type (2018-2029)
4.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Type (2018-2029)
4.2.1 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Type (2018-2023)
4.2.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Type (2024-2029)
4.2.3 Global Medical Hyaluronic Acid Viscosupplementation Revenue Market Share by Type (2018-2029)
4.3 Global Medical Hyaluronic Acid Viscosupplementation Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Hyaluronic Acid Viscosupplementation Sales by Application (2018-2029)
5.1.1 Global Medical Hyaluronic Acid Viscosupplementation Sales by Application (2018-2023)
5.1.2 Global Medical Hyaluronic Acid Viscosupplementation Sales by Application (2024-2029)
5.1.3 Global Medical Hyaluronic Acid Viscosupplementation Sales Market Share by Application (2018-2029)
5.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Application (2018-2029)
5.2.1 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Application (2018-2023)
5.2.2 Global Medical Hyaluronic Acid Viscosupplementation Revenue by Application (2024-2029)
5.2.3 Global Medical Hyaluronic Acid Viscosupplementation Revenue Market Share by Application (2018-2029)
5.3 Global Medical Hyaluronic Acid Viscosupplementation Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Anika Therapeutics
6.1.1 Anika Therapeutics Corporation Information
6.1.2 Anika Therapeutics Description and Business Overview
6.1.3 Anika Therapeutics Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Anika Therapeutics Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.1.5 Anika Therapeutics Recent Developments/Updates
6.2 Genzyme (Sanofi)
6.2.1 Genzyme (Sanofi) Corporation Information
6.2.2 Genzyme (Sanofi) Description and Business Overview
6.2.3 Genzyme (Sanofi) Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Genzyme (Sanofi) Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.2.5 Genzyme (Sanofi) Recent Developments/Updates
6.3 Bioventus
6.3.1 Bioventus Corporation Information
6.3.2 Bioventus Description and Business Overview
6.3.3 Bioventus Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bioventus Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.3.5 Bioventus Recent Developments/Updates
6.4 Seikagaku Corporation
6.4.1 Seikagaku Corporation Corporation Information
6.4.2 Seikagaku Corporation Description and Business Overview
6.4.3 Seikagaku Corporation Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Seikagaku Corporation Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.4.5 Seikagaku Corporation Recent Developments/Updates
6.5 LG Chem
6.5.1 LG Chem Corporation Information
6.5.2 LG Chem Description and Business Overview
6.5.3 LG Chem Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.5.4 LG Chem Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.5.5 LG Chem Recent Developments/Updates
6.6 Zimmer Biomet
6.6.1 Zimmer Biomet Corporation Information
6.6.2 Zimmer Biomet Description and Business Overview
6.6.3 Zimmer Biomet Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zimmer Biomet Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.6.5 Zimmer Biomet Recent Developments/Updates
6.7 Swiss Biomed Orthopaedics
6.6.1 Swiss Biomed Orthopaedics Corporation Information
6.6.2 Swiss Biomed Orthopaedics Description and Business Overview
6.6.3 Swiss Biomed Orthopaedics Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Swiss Biomed Orthopaedics Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.7.5 Swiss Biomed Orthopaedics Recent Developments/Updates
6.8 TRB Chemedica
6.8.1 TRB Chemedica Corporation Information
6.8.2 TRB Chemedica Description and Business Overview
6.8.3 TRB Chemedica Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.8.4 TRB Chemedica Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.8.5 TRB Chemedica Recent Developments/Updates
6.9 KalVista Pharma
6.9.1 KalVista Pharma Corporation Information
6.9.2 KalVista Pharma Description and Business Overview
6.9.3 KalVista Pharma Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.9.4 KalVista Pharma Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.9.5 KalVista Pharma Recent Developments/Updates
6.10 Macopharma
6.10.1 Macopharma Corporation Information
6.10.2 Macopharma Description and Business Overview
6.10.3 Macopharma Medical Hyaluronic Acid Viscosupplementation Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Macopharma Medical Hyaluronic Acid Viscosupplementation Product Portfolio
6.10.5 Macopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Hyaluronic Acid Viscosupplementation Industry Chain Analysis
7.2 Medical Hyaluronic Acid Viscosupplementation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Hyaluronic Acid Viscosupplementation Production Mode & Process
7.4 Medical Hyaluronic Acid Viscosupplementation Sales and Marketing
7.4.1 Medical Hyaluronic Acid Viscosupplementation Sales Channels
7.4.2 Medical Hyaluronic Acid Viscosupplementation Distributors
7.5 Medical Hyaluronic Acid Viscosupplementation Customers
8 Medical Hyaluronic Acid Viscosupplementation Market Dynamics
8.1 Medical Hyaluronic Acid Viscosupplementation Industry Trends
8.2 Medical Hyaluronic Acid Viscosupplementation Market Drivers
8.3 Medical Hyaluronic Acid Viscosupplementation Market Challenges
8.4 Medical Hyaluronic Acid Viscosupplementation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
